Our Story
We began in 2017 to reduce stigma around men's health. Since then, we have completed 50 million+ consultations, expanded our areas of care, and served millions of subscribers around the world through our telehealth platform.
2017
Hims Launches
Our CEO Andrew Dudum launched Hims with the goal of destigmatizing and simplifying care for common men's health conditions, starting with hair loss and erectile dysfunction.
2018
Hers Launches
One year later, our team launched Hers to provide support for women seeking birth control, hair regrowth, and skincare.
2019
Reach $1 billion valuation
We became one of the fastest digital health companies to reach a $1 billion valuation following our $100 million in a Series C fundraising round.
2020–2021
Expand our operations
We opened an Ohio-affiliated pharmacy to provide our customers more seamless service. In January 2021, we went public on the NYSE (HIMS).
2022–2023
Grow our capabilities
Our new diagnostic capabilities support lab-based personalized care and help providers incorporate additional health information into care plans.
2024–2025
Expand our business
We expanded into GLP-1 weight management, hormone health, and Labs, and launched international operations.
2026
Launch AI-native care and acquire Eucalyptus
We introduced our AI clinical engine, which powers a doctor-led, AI-native care experience that connects every part of the care journey. We also acquired Eucalyptus, expanding our reach into Australia and other international markets.
